Skip to main content
Caplight Logo









Medication Data Science

Medication Data Science

Private
Ann Arbor, MichiganHealthcare & Life Scienceshttps://meds-ai.com

Last Round

Accelerator

Sep 25, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Medication Data Science is a health technology company that provides AI-powered tools and data pipelines to secure medication workflows, reduce dispensing errors, and improve clinical outcomes for pharmacies.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Medical AI, Vertical SaaS, Compliance & Risk

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

dispensing analyticsmedication workflowPBM audit riskdispensing error reductionpharmacy softwaremedication therapy managementMTMpharmacy informaticshealth techclinical decision supportmedical AIhealthcare analyticspharmacy automationreal-world data analysisRxNorm

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medication Data Science Comparables

Compare Medication Data Science with similar companies based on industry and business-model similarity.

Medication Data Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Asepha
81%
Arine
77%
Bainbridge Health
77%

Medication Data Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 25, 2025

Medication Data Science Investors

Notable investors and investment history

Medication Data Science investors
InvestorRounds
Accelerate Blue FundAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 25, 2025

    Received funding from Accelerate Blue Fund.

Medication Data Science Filings

Explore SEC and related filing metadata, where available.

Medication Data Science filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Medication Data Science's valuation, stock price, and market status.

Is Medication Data Science a public or private company?

Medication Data Science is a private company.

What is the current stock price of Medication Data Science?

Medication Data Science is a private company with no public stock price. No recent secondary market data is available.

How much is Medication Data Science worth (valuation)?

Valuation information for Medication Data Science is not publicly available.

Can I buy Medication Data Science stock?

Medication Data Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Medication Data Science's last funding round?

Medication Data Science's most recent funding round was Accelerator on September 25, 2025.

Who are the main investors in Medication Data Science?

Key investors in Medication Data Science include Accelerate Blue Fund.

Will Medication Data Science IPO soon?

No public IPO plans have been announced for Medication Data Science.

How can I track Medication Data Science secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medication Data Science's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAnn Arbor, Michigan
Year FoundedN/A
Last FundingSep 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?